Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

NEW YORK, Nov. 22, 2019

NEW YORK, Nov. 22, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary duties and other violations of law related to merger and acquisition agreements.

(PRNewsfoto/Moore Kuehn, PLLC)

SRC Energy, Inc. (NYSE: SRCI)

SRC Energy, Inc. has agreed to be acquired by PDC Energy, Inc. Under the terms of the agreement, SRC shareholders will receive a fixed exchange ratio of 0.158 PDC shares for each share of SRC common stock, representing an implied value of $3.99 per share based on the PDC closing price as of August 23, 2019.

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN)

Achillion Pharmaceuticals has agreed to be acquired by Alexion. The initial consideration of approximately $930 million, or $6.30 per share of Achillion common stock, will be funded with cash on hand. As part of the acquisition, Alexion will also be acquiring the cash currently on Achillion's balance sheet.

Arotech Corporation (NASDAQ: ARTX)

ARIVA.DE Börsen-Geflüster

Kurse

Achillion Pharmaceuticals

0,00%

Arotech

0,00%

SRC ENERGY INC.

0,00%

Arotech Corporation announced that it has entered into a definitive agreement with an affiliate of Greenbriar Equity Group, L.P. under which the affiliate will acquire all outstanding shares of Arotech common stock for $3.00 per share in cash, representing an aggregate equity value of approximately $80.8 million.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process. Moore Kuehn may ultimately seek an increased share price, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies.

Moore Kuehn encourages shareholders to contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245. There is no cost or obligation to you.

Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims. For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8^th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245

View original content to download multimedia:http://www.prnewswire.com/news-releases/moore-kuehn-pllc-encourages-investors-of-src-energy-inc-srci-achillion-pharmaceuticals-inc-achn-and-arotech-corporation-artx-to-contact-firm-300963839.html

SOURCE Moore Kuehn, PLLC

Mehr Nachrichten zur Achillion Pharmaceuticals Aktie kostenlos abonnieren

E-Mail-Adresse

Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.